IP Library Granted Patent US 10,538,814
Granted Patent B2
US 10,538,814 · App. 16/399,268 · Granted Jan 21, 2020

Methods for simultaneous amplification of target loci

Inventors: Joshua Babiarz (Castro Valley, CA); Tudor Pompiliu Constantin (Berkeley, CA); Lane A. Eubank (San Carlos, CA); George Gemelos (Portland, OR); Matthew Micah Hill (Belmont, CA); Huseyin Eser Kirkizlar (Los Angeles, CA); Matthew Rabinowitz (San Francisco, CA); Onur Sakarya (Redwood City, CA); Styrmir Sigurjonsson (San Jose, CA); Bernhard Zimmermann (Manteca, CA)
Assignee: Natera, Inc.
C12Q1/6883C12Q1/6811C12Q1/6848C12Q2600/156
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,538,814
App. No.
16/399,268
Granted
Jan 21, 2020
Kind
B2
Abstract

The invention provides methods for simultaneously amplifying multiple nucleic acid regions of interest in one reaction volume as well as methods for selecting a library of primers for use in such amplification methods. The invention also provides library of primers with desirable characteristics, such as minimal formation of amplified primer dimers or other non-target amplicons.

Claims (31)

1. A method for amplifying and sequencing DNA, comprising:

ligating adaptors to cell-free DNA isolated from a biological sample, wherein the adaptors each comprises a universal priming site;

performing a first PCR to simultaneously amplify at least 10 target loci using a universal primer and at least 10 target-specific primers in a single reaction volume;

performing a second, nested PCR to simultaneously amplify the at least 10 target loci using the universal primer and at least 10 inner target-specific primers in a single reaction volume, wherein at least one of the primers comprises a sequencing tag;

performing high-throughput sequencing to sequence the amplified DNA comprising the target loci.

2. The method of claim 1 , wherein the biological sample is a blood, plasma, serum, or urine sample.

3. The method of claim 1 , wherein the method comprises subjecting the isolated cell-free DNA to blunting ending, dA-tailing, and adaptor ligation.

4. The method of claim 1 , wherein the adaptor further comprises a molecular barcode.

5. The method of claim 1 , wherein the second PCR is one-sided nested PCR.

6. The method of claim 1 , wherein the method comprises multiplex sequencing of amplified DNA of multiple samples in a single sequencing lane.

7. The method of claim 1 , wherein the first PCR comprises simultaneously amplifying at least 50 target loci using the universal primer and at least 50 target-specific primers in a single reaction volume.

8. The method of claim 1 , wherein the first PCR comprises simultaneously amplifying at least 100 target loci using the universal primer and at least 100 target-specific primers in a single reaction volume.

9. The method of claim 1 , wherein the second PCR comprises simultaneously amplifying at least 50 target loci using the universal primer and at least 50 inner target-specific primers in a single reaction volume.

10. The method of claim 1 , wherein the second PCR comprises simultaneously amplifying at least 100 target loci using the universal primer and at least 100 inner target-specific primers in a single reaction volume.

11. The method of claim 4 , wherein the isolated cell-free DNA are tagged with up to 1024 different molecular barcodes.

12. The method of claim 4 , wherein the isolated cell-free DNA are tagged with 1024-65536 different molecular barcodes.

13. The method of claim 1 , wherein the concentration of each target-specific primer of the first and/or second PCR is less than 20 nM.

14. The method of claim 1 , wherein the concentration of each target-specific primer of the first and/or second PCR is less than 10 nM.

15. The method of claim 1 , wherein the length of the annealing step of the first and/or second PCR is at least 3 minutes.

16. The method of claim 1 , wherein the length of the annealing step of the first and/or second PCR is at least 5 minutes.

17. The method of claim 1 , wherein at least 90% of the amplified DNA map to the target loci.

18. The method of claim 1 , wherein the target loci are SNP loci.

19. The method of claim 1 , wherein the cell-free DNA comprises DNA from mixed origin.

20. The method of claim 19 , wherein the cell-free DNA comprises DNA from a fetus.

21. The method of claim 19 , wherein the cell-free DNA comprises DNA from a tumor.

22. The method of claim 19 , wherein the cell-free DNA comprises DNA from a transplant.

23. A method for amplifying and sequencing DNA, comprising:

ligating adaptors to cell-free DNA isolated from a biological sample, wherein the adaptors each comprises a universal priming site, wherein the cell-free DNA comprises DNA from mixed origin;

performing a first PCR to simultaneously amplify at least 100 target loci using a universal primer and at least 100 target-specific primers in a single reaction volume;

performing a second, one-sided nested PCR to simultaneously amplify the at least 100 target loci using the universal primer and at least 100 inner target-specific primers in a single reaction volume, wherein at least one of the primers comprises a sequencing tag;

performing high-throughput sequencing to sequence the amplified DNA comprising the target loci, wherein the target loci are SNP loci, and wherein amplified DNAs of multiple samples are pooled and sequenced in a single sequencing lane.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2021
From: BANER, JOHAN; BANJEVIC, MILENA; RYAN, ALLISON; DEMKO, ZACHARY
To: GENE SECURITY NETWORK, INC.
Reel/Frame 056585/0642 →
CHANGE OF NAME Recorded Jun 18, 2021
From: GENE SECURITY NETWORK INC.
To: NATERA, INC.
Reel/Frame 056628/0175 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2019
From: BABIARZ, JOSHUA; CONSTANTIN, TUDOR POMPILIU; EUBANK, LANE A.; GEMELOS, GEORGE; HILL, MATTHEW; KIRKIZLAR, HUSEYIN ESER; RABINOWITZ, MATTHEW; SAKARYA, ONUR; SIGURJONSSON, STYRMIR; ZIMMERMANN, BERNHARD
To: NATERA, INC.
Reel/Frame 049043/0001 →
Continuity (40)
Continuation 16140298 · Sep 24, 2018
Continuation 14918544 · Oct 20, 2015
Continuation In Part 14877925 · Oct 7, 2015
Continuation In Part 14692703 · Apr 21, 2015
Continuation In Part 14538982 · Nov 24, 2014
Continuation In Part 14225356 · Mar 25, 2014
Continuation In Part 13780022 · Feb 28, 2013
Continuation In Part 13683604 · Nov 21, 2012
Continuation PCTUS2012058578 · Oct 3, 2012
Continuation In Part 13683604 · Nov 21, 2012
Continuation In Part PCTUS2012058578 · Oct 3, 2012
Continuation In Part 13335043 · Dec 22, 2011
Continuation In Part 13300235 · Nov 18, 2011
Continuation In Part 13110685 · May 18, 2011
Continuation In Part 13300235 · Nov 18, 2011
Continuation In Part 13110685 · May 18, 2011
Continuation In Part 13300235 · Nov 18, 2011
Continuation In Part 13300235 · Nov 18, 2011
Continuation In Part 13110685 · May 18, 2011
Continuation In Part 13110685 · May 18, 2011
Provisional Application 62148173 · Apr 15, 2015
Provisional Application 62147377 · Apr 14, 2015
Provisional Application 62146188 · Apr 10, 2015
Provisional Application 62066514 · Oct 21, 2014
Provisional Application 62148173 · Apr 15, 2015
Provisional Application 61994791 · May 16, 2014
Provisional Application 61987407 · May 1, 2014
Provisional Application 61982245 · Apr 21, 2014
Provisional Application 61634431 · Feb 29, 2012
Provisional Application 61675020 · Jul 24, 2012
Provisional Application 61683331 · Aug 15, 2012
Provisional Application 61542508 · Oct 3, 2011
Provisional Application 61426208 · Dec 22, 2010
Provisional Application 61571248 · Jun 23, 2011
Provisional Application 61516996 · Apr 12, 2011
Provisional Application 61448547 · Mar 2, 2011
Provisional Application 61462972 · Feb 9, 2011
Provisional Application 61398159 · Jun 21, 2010
Provisional Application 61395850 · May 18, 2010
Related Publication 20190256917A1 · Aug 22, 2019
Cited By (40)
US 12,195,803 US 12,203,142 US 12,209,281 US 12,221,653 US 12,234,509 US 12,252,743 US 12,260,934 US 12,270,073 US 12,281,354 US 12,305,229 US 12,305,235 US 12,385,096 US 12,410,476 US 12,442,038 US 12,460,264 US 12,462,935 US 12,486,542 US 12,492,429 US 12,494,267 US 12,509,728 US 12,509,730 US 12,534,759 US 12,545,960 US 12,553,082 US 12,553,083 US 12,553,086 US 12,553,087 US 12,571,034 US 12,571,043 US 12,571,047 US 12,584,175 US 12,644,149 US 12,649,946 US 12,655,483 US 12,662,697 US 12,662,704 US 12,668,843 US 12,692,544 US 12,716,090 US 12,716,100